loadpatents
Patent applications and USPTO patent grants for Chan; Tin-Yau.The latest application filed is for "heterocyclic compounds as hiv protease inhibitors".
Patent | Date |
---|---|
Heterocyclic Compounds As Hiv Protease Inhibitors App 20200261421 - McKittrick; Brian ;   et al. | 2020-08-20 |
Heterocyclic Compounds As Hiv Protease Inhibitors App 20200069691 - McKittrick; Brian ;   et al. | 2020-03-05 |
Factor IXa inhibitors Grant 9,695,198 - Smith , et al. July 4, 2 | 2017-07-04 |
Factor IXa Inhibitors App 20150368269 - Smith; Cameron James ;   et al. | 2015-12-24 |
Morpholinone compounds as factor IXA inhibitors Grant 8,987,242 - Chackalamannil , et al. March 24, 2 | 2015-03-24 |
Fused-imidazoyl compounds useful as antimicrobial agents Grant 8,871,929 - Chan , et al. October 28, 2 | 2014-10-28 |
3-heterocyclic substituted indole derivatives and methods of use thereof Grant 8,765,757 - Chan , et al. July 1, 2 | 2014-07-01 |
Inhibitors of diacylglycerol acyltransferase Grant 8,716,312 - Ting , et al. May 6, 2 | 2014-05-06 |
Substituted pyrazolo[1,5-a]pyrimidines as cyclin dependent kinase inhibitors Grant 8,673,924 - Guzi , et al. March 18, 2 | 2014-03-18 |
Morpholinone compounds as factor IXa inhibitors Grant 8,642,582 - Nishida , et al. February 4, 2 | 2014-02-04 |
Substituted indole derivatives and methods of use thereof Grant 8,614,229 - Anilkumar , et al. December 24, 2 | 2013-12-24 |
4, 5, 6-trisubstituted pyrimidine derivatives as factor IXa inhibitors Grant 8,609,676 - Chelliah , et al. December 17, 2 | 2013-12-17 |
Fused-imidazoyl Compounds Useful As Antimicrobial Agents App 20130210816 - Chan; Tin-Yau ;   et al. | 2013-08-15 |
MEK1 polypeptides Grant 8,440,443 - Fischmann , et al. May 14, 2 | 2013-05-14 |
4, 5, 6-trisubstituted Pyrimidine Derivatives As Factor Ixa Inhibitors App 20120136016 - Chelliah; Mariappan V. ;   et al. | 2012-05-31 |
Peptides as NS3-serine protease inhibitors of hepatitis C virus Grant RE43,298 - Saksena , et al. April 3, 2 | 2012-04-03 |
Heterocyclic compounds as factor IXA inhibitors Grant 8,148,363 - Clasby , et al. April 3, 2 | 2012-04-03 |
2,3-substituted indole derivatives for treating viral infections Grant 8,143,305 - Anilkumar , et al. March 27, 2 | 2012-03-27 |
Inhibitors Of Diacylglycerol Acyltransferase App 20110224137 - Ting; Pauline C. ;   et al. | 2011-09-15 |
Inhibitors Of Diacylglycerol Acyltransferase App 20110224193 - Ting; Pauline C. ;   et al. | 2011-09-15 |
3-heterocyclic Substituted Indole Derivatives And Methods Of Use Thereof App 20110165118 - Chan; Tin-Yau ;   et al. | 2011-07-07 |
Morpholinone Compounds As Factor Ixa Inhibitors App 20110135650 - CHACKALAMANNIL; Samuel ;   et al. | 2011-06-09 |
Novel Peptides As Ns3-serine Protease Inhibitors Of Hepatitis C Virus App 20110117057 - Saksena; Anil K. ;   et al. | 2011-05-19 |
Substituted Indole Derivatives And Methods Of Use Thereof App 20110104110 - Anikumar; Gopinadhan N. ;   et al. | 2011-05-05 |
Heterocyclic Compounds As Factor Ixa Inhibitors App 20110065682 - Clasby; Martin C. ;   et al. | 2011-03-17 |
Morpholinone Compounds As Factor Ixa Inhibitors App 20110059958 - Nishida; Hidemitsu ;   et al. | 2011-03-10 |
2,3-substituted Indole Derivatives For Treating Viral Infections App 20110033417 - Anilkumar; Gopinadhan N. ;   et al. | 2011-02-10 |
Azetidinone derivatives and methods of use thereof Grant 7,884,080 - Aslanian , et al. February 8, 2 | 2011-02-08 |
N-heteroaryl pyrazolopyrimidines as cyclin dependent kinase inhibitors Grant 7,807,683 - Guzi , et al. October 5, 2 | 2010-10-05 |
Compounds For The Treatment Of Inflammatory Disorders App 20100145048 - Guo; Zhuyan ;   et al. | 2010-06-10 |
Substituted indazoles of formula 1.0 that are kinase inhibitors Grant 7,700,601 - Chan , et al. April 20, 2 | 2010-04-20 |
Compounds for the treatment of inflammatory disorders Grant 7,652,020 - Guo , et al. January 26, 2 | 2010-01-26 |
Peptides as NS3-serine protease inhibitors of hepatitis C virus Grant 7,595,299 - Saksena , et al. September 29, 2 | 2009-09-29 |
Kinase inhibitors Grant 7,528,132 - Chan , et al. May 5, 2 | 2009-05-05 |
Trisubstituted 4-aminopyrazolopyrimidines as cyclin dependent kinase inhibitors Grant 7,514,442 - Guzi , et al. April 7, 2 | 2009-04-07 |
MCH antagonists and their use in the treatment of obesity Grant 7,452,891 - Clader , et al. November 18, 2 | 2008-11-18 |
Azetidinone Derivatives and Methods of Use Thereof App 20080076750 - Aslanian; Robert G. ;   et al. | 2008-03-27 |
Azetidinone Derivatives and Methods of Use Thereof App 20080076751 - Aslanian; Robert G. ;   et al. | 2008-03-27 |
Novel pyrazolopyrimidines as cyclin dependent kinase inhibitors App 20080050384 - Guzi; Timothy J. ;   et al. | 2008-02-28 |
Kinase inhibitors App 20080021019 - Chan; Tin-Yau ;   et al. | 2008-01-24 |
Kinase inhibitors App 20080004257 - Chan; Tin-Yau ;   et al. | 2008-01-03 |
Peptides as NS3-serine protease inhibitors of hepatitis C virus Grant 7,244,721 - Saksena , et al. July 17, 2 | 2007-07-17 |
Novel pyrazolopyrimidines as cyclin dependent kinase inhibitors App 20070054925 - Guzi; Timothy J. ;   et al. | 2007-03-08 |
Novel pyrazolopyrimidines as cyclin dependent kinase inhibitors App 20070054906 - Guzi; Timothy J. ;   et al. | 2007-03-08 |
Novel pyrazolopyrimidines as cyclin dependent kinase inhibitors App 20070037824 - Guzi; Timothy J. ;   et al. | 2007-02-15 |
Novel peptides as NS3-serine protease inhibitors of hepatitis C virus App 20070032433 - Saksena; Anil K. ;   et al. | 2007-02-08 |
Peptides as NS3-serine protease inhibitors of hepatitis C virus Grant 7,169,760 - Saksena , et al. January 30, 2 | 2007-01-30 |
Pyrazolopyrimidines as cyclin dependent kinase inhibitors Grant 7,161,003 - Guzi , et al. January 9, 2 | 2007-01-09 |
Compounds for the treatment of inflammatory disorders App 20060252778 - Guo; Zhuyan ;   et al. | 2006-11-09 |
Pyrazolopyrimidines as cyclin dependent kinase inhibitors Grant 7,119,200 - Guzi , et al. October 10, 2 | 2006-10-10 |
Novel peptides as NS3-serine protease inhibitors of hepatitis C virus App 20060205672 - Saksena; Anil K. ;   et al. | 2006-09-14 |
Novel pyrazolopyrimidines as cyclin dependent kinase inhibitors App 20060178371 - Guzi; Timothy J. ;   et al. | 2006-08-10 |
Pyrazolopyrimidines as cyclin dependent kinase inhibitors Grant 7,067,661 - Guzi , et al. June 27, 2 | 2006-06-27 |
Peptides as NS3-serine protease inhibitors of hepatitis C virus Grant 7,012,066 - Saksena , et al. March 14, 2 | 2006-03-14 |
Novel peptides as NS3-serine protease inhibitors of hepatitis C virus App 20050176648 - Saksena, Anil K. ;   et al. | 2005-08-11 |
MCH antagonists and their use in the treatment of obesity App 20050171098 - Clader, John W. ;   et al. | 2005-08-04 |
Macrocyclic NS-3 serine protease inhibitors of hepatitis C virus comprising alkyl and aryl alanine P2 moieties Grant 6,914,122 - Venkatraman , et al. July 5, 2 | 2005-07-05 |
MCH antagonists and their use in the treatment of obesity Grant 6,900,329 - Clader , et al. May 31, 2 | 2005-05-31 |
Novel peptides as NS3-serine protease inhibitors of hepatitis C virus App 20040254117 - Saksena, Anil K. ;   et al. | 2004-12-16 |
Novel pyrazolopyrimidines as cyclin dependent kinase inhibitors App 20040209878 - Guzi, Timothy J. ;   et al. | 2004-10-21 |
Novel pyrazolopyrimidines as cyclin dependent kinase inhibitors App 20040106624 - Guzi, Timothy J. ;   et al. | 2004-06-03 |
Novel peptides as NS3-serine protease inhibitors of hepatitis C virus App 20030216325 - Saksena, Anil K. ;   et al. | 2003-11-20 |
MCH antagonists and their use in the treatment of obesity App 20030105094 - Clader, John W. ;   et al. | 2003-06-05 |
Novel peptides as NS3-serine protease inhibitors of hepatitis C virus App 20020160962 - Saksena, Anil K. ;   et al. | 2002-10-31 |
Macrocyclic NS-3 serine protease inhibitors of hepatitis C virus comprising alkyl and aryl alanine P2 moieties App 20020016294 - Venkatraman, Srikanth ;   et al. | 2002-02-07 |
Combinatorial library of moenomycin analogs and methods of producing same Grant 6,114,309 - Allanson , et al. September 5, 2 | 2000-09-05 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.